159 related articles for article (PubMed ID: 29750961)
1. Apolipoprotein M promotes proliferation and invasion in non-small cell lung cancers via upregulating S1PR1 and activating the ERK1/2 and PI3K/AKT signaling pathways.
Zhu Y; Luo G; Jiang B; Yu M; Feng Y; Wang M; Xu N; Zhang X
Biochem Biophys Res Commun; 2018 Jun; 501(2):520-526. PubMed ID: 29750961
[TBL] [Abstract][Full Text] [Related]
2. ApoM-S1P Modulates Ox-LDL-Induced Inflammation Through the PI3K/Akt Signaling Pathway in HUVECs.
Zheng Z; Zeng Y; Zhu X; Tan Y; Li Y; Li Q; Yi G
Inflammation; 2019 Apr; 42(2):606-617. PubMed ID: 30377890
[TBL] [Abstract][Full Text] [Related]
3. Apolipoprotein M supports S1P production and conservation and mediates prolonged Akt activation via S1PR1 and S1PR3.
Kiyozuka K; Zhao X; Konishi A; Minamishima YA; Obinata H
J Biochem; 2023 Jul; 174(3):253-266. PubMed ID: 37098187
[TBL] [Abstract][Full Text] [Related]
4. Apolipoprotein M and sphingosine-1-phosphate complex alleviates TNF-α-induced endothelial cell injury and inflammation through PI3K/AKT signaling pathway.
Liu Y; Tie L
BMC Cardiovasc Disord; 2019 Dec; 19(1):279. PubMed ID: 31791242
[TBL] [Abstract][Full Text] [Related]
5. Induction of insulin secretion by apolipoprotein M, a carrier for sphingosine 1-phosphate.
Kurano M; Hara M; Tsuneyama K; Sakoda H; Shimizu T; Tsukamoto K; Ikeda H; Yatomi Y
Biochim Biophys Acta; 2014 Sep; 1841(9):1217-26. PubMed ID: 24814049
[TBL] [Abstract][Full Text] [Related]
6. Sphingosine-1-phosphate promotes the proliferation and attenuates apoptosis of Endothelial progenitor cells via S1PR1/S1PR3/PI3K/Akt pathway.
Wang H; Huang H; Ding SF
Cell Biol Int; 2018 Nov; 42(11):1492-1502. PubMed ID: 29790626
[TBL] [Abstract][Full Text] [Related]
7. Apolipoprotein M Protects Against Lipopolysaccharide-Induced Acute Lung Injury via Sphingosine-1-Phosphate Signaling.
Zhu B; Luo GH; Feng YH; Yu MM; Zhang J; Wei J; Yang C; Xu N; Zhang XY
Inflammation; 2018 Mar; 41(2):643-653. PubMed ID: 29260347
[TBL] [Abstract][Full Text] [Related]
8. Apolipoprotein M induces inhibition of inflammatory responses via the S1PR1 and DHCR24 pathways.
Wang M; Luo GH; Liu H; Zhang YP; Wang B; Di DM; Zhan XH; Yu Y; Yao S; Zhang XY; Xu N
Mol Med Rep; 2019 Feb; 19(2):1272-1283. PubMed ID: 30569161
[TBL] [Abstract][Full Text] [Related]
9. High-Density Lipoprotein-Associated Apolipoprotein M Limits Endothelial Inflammation by Delivering Sphingosine-1-Phosphate to the Sphingosine-1-Phosphate Receptor 1.
Ruiz M; Frej C; Holmér A; Guo LJ; Tran S; Dahlbäck B
Arterioscler Thromb Vasc Biol; 2017 Jan; 37(1):118-129. PubMed ID: 27879252
[TBL] [Abstract][Full Text] [Related]
10. Propofol promotes migration, alleviates inflammation, and apoptosis of lipopolysaccharide-induced human pulmonary microvascular endothelial cells by activating PI3K/AKT signaling pathway via upregulating APOM expression.
Wang L; Tang X; Li S
Drug Dev Res; 2022 Apr; 83(2):397-406. PubMed ID: 34418885
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-92a promotes epithelial-mesenchymal transition through activation of PTEN/PI3K/AKT signaling pathway in non-small cell lung cancer metastasis.
Lu C; Shan Z; Hong J; Yang L
Int J Oncol; 2017 Jul; 51(1):235-244. PubMed ID: 28534966
[TBL] [Abstract][Full Text] [Related]
12. Alpha-enolase promotes cell glycolysis, growth, migration, and invasion in non-small cell lung cancer through FAK-mediated PI3K/AKT pathway.
Fu QF; Liu Y; Fan Y; Hua SN; Qu HY; Dong SW; Li RL; Zhao MY; Zhen Y; Yu XL; Chen YY; Luo RC; Li R; Li LB; Deng XJ; Fang WY; Liu Z; Song X
J Hematol Oncol; 2015 Mar; 8():22. PubMed ID: 25887760
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of ELF3 facilitates cell growth and metastasis through PI3K/Akt and ERK signaling pathways in non-small cell lung cancer.
Wang H; Yu Z; Huo S; Chen Z; Ou Z; Mai J; Ding S; Zhang J
Int J Biochem Cell Biol; 2018 Jan; 94():98-106. PubMed ID: 29208568
[TBL] [Abstract][Full Text] [Related]
14. HDL-associated ApoM is anti-apoptotic by delivering sphingosine 1-phosphate to S1P1 & S1P3 receptors on vascular endothelium.
Ruiz M; Okada H; Dahlbäck B
Lipids Health Dis; 2017 Feb; 16(1):36. PubMed ID: 28179022
[TBL] [Abstract][Full Text] [Related]
15. ApoA-I/SR-BI modulates S1P/S1PR2-mediated inflammation through the PI3K/Akt signaling pathway in HUVECs.
Ren K; Lu YJ; Mo ZC; -Liu X; Tang ZL; Jiang Y; Peng XS; Li L; Zhang QH; Yi GH
J Physiol Biochem; 2017 May; 73(2):287-296. PubMed ID: 28181168
[TBL] [Abstract][Full Text] [Related]
16. Activation of M3 muscarinic receptor by acetylcholine promotes non-small cell lung cancer cell proliferation and invasion via EGFR/PI3K/AKT pathway.
Xu R; Shang C; Zhao J; Han Y; Liu J; Chen K; Shi W
Tumour Biol; 2015 Jun; 36(6):4091-100. PubMed ID: 25964092
[TBL] [Abstract][Full Text] [Related]
17. ZNF452 facilitates tumor proliferation and invasion via activating AKT-GSK3β signaling pathway and predicts poor prognosis of non-small cell lung cancer patients.
Zhang X; Zhou H; Zhang Y; Cai L; Jiang G; Li A; Miao Y; Li Q; Qiu X; Wang E
Oncotarget; 2017 Jun; 8(24):38863-38875. PubMed ID: 28418919
[TBL] [Abstract][Full Text] [Related]
18. MiR-101-3p inhibits the growth and metastasis of non-small cell lung cancer through blocking PI3K/AKT signal pathway by targeting MALAT-1.
Zhang X; He X; Liu Y; Zhang H; Chen H; Guo S; Liang Y
Biomed Pharmacother; 2017 Sep; 93():1065-1073. PubMed ID: 28738500
[TBL] [Abstract][Full Text] [Related]
19. Endothelium-protective sphingosine-1-phosphate provided by HDL-associated apolipoprotein M.
Christoffersen C; Obinata H; Kumaraswamy SB; Galvani S; Ahnström J; Sevvana M; Egerer-Sieber C; Muller YA; Hla T; Nielsen LB; Dahlbäck B
Proc Natl Acad Sci U S A; 2011 Jun; 108(23):9613-8. PubMed ID: 21606363
[TBL] [Abstract][Full Text] [Related]
20. Highly expressed long non-coding RNA CRNDE promotes cell proliferation through PI3K/AKT signalling in non-small cell lung carcinoma.
Liu XX; Xiong HP; Huang JS; Qi K; Xu JJ
Clin Exp Pharmacol Physiol; 2017 Aug; 44(8):895-902. PubMed ID: 28477368
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]